Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide Vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is Correlated With Fibroblast Growth Factor 23: Sub-Analysis Results Of...

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2022 Jul 25

PMID 35872799

Authors

Katharina Dorr

Sebastian Hodlmoser

Michael Kammer

Roman Reindl-Schwaighofer

Matthias Lorenz

Bianca Reiskopf

Rahel Jagoditsch

Rodrig Marculescu

Rainer Oberbauer

Affiliations

Soon will be listed here.

Abstract

Clinical Trial Registration: [www.ClinicalTrials.gov], identifier [NCT03182699].

Citing Articles

The effect of parathyroid hormone lowering by etelcalcetide therapy on calcification propensity and calciprotein particles in hemodialysis patients.

Thiem U, Lenz J, Haller M, Pasch A, Smith E, Cejka D Clin Kidney J. 2024; 17(6):sfae097.

PMID: 38919277 PMC: 11197474. DOI: 10.1093/ckj/sfae097.

Effect of etelcalcetide versus alfacalcidol on left ventricular function and feature-tracking cardiac magnetic resonance imaging in hemodialysis-a post-hoc analysis of a randomized, controlled trial.

Dorr K, Kammerlander A, Lauriero F, Lorenz M, Marculescu R, Beitzke D J Cardiovasc Magn Reson. 2023; 25(1):62.

PMID: 37932788 PMC: 10626812. DOI: 10.1186/s12968-023-00975-4.

References

Scialla J, Xie H, Rahman M, Anderson A, Isakova T, Ojo A . Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol. 2013; 25(2):349-60. PMC: 3904568. DOI: 10.1681/ASN.2013050465. View

Yu L, Tomlinson J, Alexander S, Hensley K, Han C, Dwyer D . Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism. Calcif Tissue Int. 2017; 101(6):641-653. PMC: 5660836. DOI: 10.1007/s00223-017-0319-7. View

Block G, Bushinsky D, Cunningham J, Drueke T, Ketteler M, Kewalramani R . Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials. JAMA. 2017; 317(2):146-155. DOI: 10.1001/jama.2016.19456. View

Bojic M, Bielesz B, Cejka D, Schernthaner G, Hobaus C . Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease. Thromb Haemost. 2021; 122(6):1040-1046. DOI: 10.1055/s-0041-1736444. View

Paloian N, Giachelli C . A current understanding of vascular calcification in CKD. Am J Physiol Renal Physiol. 2014; 307(8):F891-900. PMC: 4200295. DOI: 10.1152/ajprenal.00163.2014. View

Pasch A, Block G, Bachtler M, Smith E, Jahnen-Dechent W, Arampatzis S . Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial. Clin J Am Soc Nephrol. 2016; 12(2):315-322. PMC: 5293330. DOI: 10.2215/CJN.04720416. View

Beck-Nielsen S, Mughal Z, Haffner D, Nilsson O, Levtchenko E, Ariceta G . FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J Rare Dis. 2019; 14(1):58. PMC: 6390548. DOI: 10.1186/s13023-019-1014-8. View

Bundy J, Cai X, Scialla J, Dobre M, Chen J, Hsu C . Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis. 2019; 73(6):806-814. PMC: 6535131. DOI: 10.1053/j.ajkd.2019.01.024. View

Figge J, Jabor A, Kazda A, FENCL V . Anion gap and hypoalbuminemia. Crit Care Med. 1998; 26(11):1807-10. DOI: 10.1097/00003246-199811000-00019. View

10.

Wetmore J, Gurevich K, Sprague S, da Roza G, Buerkert J, Reiner M . A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM). Clin J Am Soc Nephrol. 2015; 10(6):1031-40. PMC: 4455208. DOI: 10.2215/CJN.07050714. View

11.

Briese S, Wiesner S, Will J, Lembcke A, Opgen-Rhein B, Nissel R . Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy. Nephrol Dial Transplant. 2006; 21(7):1906-14. DOI: 10.1093/ndt/gfl098. View

12.

Shroff R, Long D, Shanahan C . Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol. 2012; 24(2):179-89. DOI: 10.1681/ASN.2011121191. View

13.

Andrukhova O, Schuler C, Bergow C, Petric A, Erben R . Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice. Front Endocrinol (Lausanne). 2018; 9:311. PMC: 6004378. DOI: 10.3389/fendo.2018.00311. View

14.

Levin A, Bakris G, Molitch M, Smulders M, Tian J, Williams L . Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2006; 71(1):31-8. DOI: 10.1038/sj.ki.5002009. View

15.

Drechsler C, Verduijn M, Pilz S, Krediet R, Dekker F, Wanner C . Bone alkaline phosphatase and mortality in dialysis patients. Clin J Am Soc Nephrol. 2011; 6(7):1752-9. DOI: 10.2215/CJN.10091110. View

16.

Murali S, Roschger P, Zeitz U, Klaushofer K, Andrukhova O, Erben R . FGF23 Regulates Bone Mineralization in a 1,25(OH)2 D3 and Klotho-Independent Manner. J Bone Miner Res. 2015; 31(1):129-42. DOI: 10.1002/jbmr.2606. View

17.

Slouma M, Aissaoui T, Abbes M, Bahlous A, Laadhar L, Smaoui W . New Markers of Bone Fragility in Hemodialysis Patients: A Monocentric Study. J Clin Densitom. 2020; 24(1):22-27. DOI: 10.1016/j.jocd.2020.11.002. View

18.

Ishimura E, Okuno S, Okazaki H, Norimine K, Yamakawa K, Yamakawa T . Significant association between bone-specific alkaline phosphatase and vascular calcification of the hand arteries in male hemodialysis patients. Kidney Blood Press Res. 2014; 39(4):299-307. DOI: 10.1159/000355807. View

19.

Iba K, Takada J, Yamashita T . The serum level of bone-specific alkaline phosphatase activity is associated with aortic calcification in osteoporosis patients. J Bone Miner Metab. 2004; 22(6):594-6. DOI: 10.1007/s00774-004-0528-9. View

20.

Block G, Bushinsky D, Cheng S, Cunningham J, Dehmel B, Drueke T . Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial. JAMA. 2017; 317(2):156-164. DOI: 10.1001/jama.2016.19468. View